4.8 Review

The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue

Related references

Note: Only part of the references are listed.
Review Allergy

A Review of Persistent Post-COVID Syndrome (PPCS)

Bryan Oronsky et al.

Summary: Persistent post-COVID syndrome, a pathologic entity, involves persistent physical, medical, and cognitive sequelae following COVID-19. The syndrome includes immunosuppression and organ fibrosis, and its potential long-term effects place a burden on healthcare systems, patients' families, and society.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Article Infectious Diseases

Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID

Benjamin Giszas et al.

Summary: This study investigated long-term symptoms and quality of life (QoL) after SARS-CoV-2 infection, finding that only about one-third of patients experienced a significant reduction in QoL, while the rest had a near-normal QoL. This suggests a differentiation between post-COVID disease and post-COVID condition.

INFECTION (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome

Andrea Dressing et al.

Summary: During the long-term phase after COVID-19 infection, patients may experience cognitive deficits and fatigue. In this study, cognitive testing and brain glucose metabolism imaging showed minor impairments in cognitive domains and no distinct pathological changes. This differs from previous findings in subacute COVID-19 patients and may be related to the high prevalence of fatigue.

JOURNAL OF NUCLEAR MEDICINE (2022)

Review Immunology

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis

Felicia Ceban et al.

Summary: Post-COVID-19 syndrome, characterized by persistent symptoms after resolution of acute infection, is associated with significant fatigue and cognitive impairment. This study aimed to quantify the proportion of individuals experiencing fatigue and cognitive impairment 12 or more weeks after COVID-19 diagnosis, and to explore the inflammatory and functional consequences of post-COVID-19 syndrome. The results showed that a significant proportion of individuals continue to experience fatigue and cognitive impairment even after 12 or more weeks of COVID-19 diagnosis. Additionally, some individuals showed elevated levels of inflammatory markers and significant functional impairment.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Review Clinical Neurology

Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis

Lavienraj Premraj et al.

Summary: Neurological and neuropsychiatric symptoms that persist or develop three months after the onset of COVID-19 pose a significant threat to the global healthcare system. A systematic review analyzed data from multiple studies and found that fatigue, cognitive dysfunction, and sleep disturbances were key features of post-COVID-19 syndrome. Psychiatric manifestations such as anxiety and depression were also common and increased in prevalence over time.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Article Clinical Neurology

Home treatment against fatigue in multiple sclerosis by a personalized, bilateral whole-body somatosensory cortex stimulation

Franca Tecchio et al.

Summary: Faremus, a personalized neuromodulation treatment, was found to be safe and effective when applied at patients' home, improving fatigue symptoms and offering a comfortable treatment option.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

Review Clinical Neurology

Neuromodulation Strategies to Reduce Inflammation and Improve Lung Complications in COVID-19 Patients

Christopher J. Czura et al.

Summary: Since the outbreak of the COVID-19 pandemic, there has been a race in academia and industry to identify and develop therapeutic strategies for modifying or preventing the disease. The focus has been on pharmacological treatment and vaccine development, with the goal of targeting the immune and respiratory systems. The hyperinflammatory state observed in many COVID-19 cases indicates a negative disease progression that can lead to severe complications. The authors propose non-invasive neuromodulation techniques as a potential solution to modulate inflammation and respiratory dysfunction caused by the virus.

FRONTIERS IN NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity

Luana Gilio et al.

Summary: Fatigue in multiple sclerosis (MS) is associated with central inflammation and disease progression. Inflammation may exacerbate fatigue. By exploring clinical characteristics and biomarkers, a negative correlation was found between fatigue levels and the cerebrospinal fluid levels of the anti-inflammatory molecule IL-10 at diagnosis.

BIOMEDICINES (2022)

Review Cell Biology

Manipulation of the inflammatory reflex as a therapeutic strategy

Mark J. Kelly et al.

Summary: The cholinergic anti-inflammatory pathway is a neural circuit that allows the central nervous system to modulate peripheral immune responses. It has been shown to play a role in various inflammatory diseases and has therapeutic potential. Pre-clinical studies have demonstrated the efficacy of this pathway, and promising clinical trials have translated these findings into potential treatments.

CELL REPORTS MEDICINE (2022)

Review Clinical Neurology

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

James B. Badenoch et al.

Summary: The prevalence and persistence of neuropsychiatric symptoms after COVID-19 infection are high. Insomnia, fatigue, cognitive impairment, anxiety, post-traumatic symptoms, and mood disorders are the most common symptoms experienced by survivors. Multidisciplinary healthcare services are necessary for COVID-19 survivors.

BRAIN COMMUNICATIONS (2022)

Article Medicine, General & Internal

Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

C. (Linda) M. C. van Campen et al.

Summary: There is overlap in symptoms and responses to tilt testing between patients with long-haul COVID-19 and ME/CFS, but the impairment of cerebral blood flow and cardiac index appears to be more severe in long-haul COVID-19 patients.

MEDICINA-LITHUANIA (2022)

Article Respiratory System

S1 Guideline Post-COVID/Long-COVID

Andreas Rembert Koczulla et al.

Summary: The guideline on Post-COVID/Long-COVID initiated by the German Society of Pneumology is designed in a broad interdisciplinary approach based on current knowledge. It describes current symptoms, diagnostic approaches, and therapies with a specific focus and practical claim for continuous development and adaptation by the author team.

PNEUMOLOGIE (2021)

Review Immunology

Psychiatric and neuropsychiatric sequelae of COVID-19-A systematic review

Thor Mertz Schou et al.

Summary: COVID-19 patients may exhibit psychiatric symptoms such as anxiety, depression, PTSD, cognitive deficits, fatigue, and sleep disturbances. Potential risk factors include disease severity, duration of symptoms, and female sex. Survivors of COVID-19 are at risk of psychiatric sequelae, but symptoms generally improve over time.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Article Clinical Neurology

The impact of individual electrical fields and anatomical factors on the neurophysiological outcomes of tDCS: A TMS-MEP and MRI study

Mohsen Mosayebi-Samani et al.

Summary: Individual anatomical factors, such as regional electrode-to-cortex distance and cerebral spinal fluid thickness, were found to significantly impact the effects of tDCS. While these factors negatively correlated with tDCS-induced physiological changes, the electrical fields positively correlated with the effects. These results provide valuable insights into the variability of neuromodulatory effects of tDCS.

BRAIN STIMULATION (2021)

Article Immunology

Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic

Karen B. Jacobson et al.

Summary: The study assessed 118 individuals 3-4 months after their initial COVID-19 diagnosis and found significant persistent symptoms and functional impairment, even in non-hospitalized patients with COVID-19.

CLINICAL INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Review Clinical Neurology

Effects of Transcranial Direct Current Stimulation on Cognition, Mood, Pain, and Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis

Wan-Yu Hsu et al.

Summary: The study suggests that transcranial direct current stimulation (tDCS) has positive effects on cognition, mood disturbance, pain, and fatigue in people with multiple sclerosis (PwMS), although the impact on cognition and fatigue varies depending on the specific assessment used.

FRONTIERS IN NEUROLOGY (2021)

Article Multidisciplinary Sciences

Anodal tDCS augments and preserves working memory beyond time-on-task deficits

Rohith Karthikeyan et al.

Summary: This study found that anodal transcranial direct current stimulation (tDCS) of the left dorsolateral prefrontal cortex significantly improved working memory performance during a fatiguing visuospatial test. However, it did not affect subjective effort or fatigue levels. Further research is needed to understand how such solutions can be applied in real-world settings.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

Cognitive impairment and a ered cerebral glucose metabolism in the subacute stage of COVID-19

Jonas A. Hosp et al.

Summary: During the COVID-19 pandemic, a prospective cohort study investigated neurological and cognitive symptoms in hospitalized patients, revealing that gustation and olfaction were commonly affected, along with cognitive impairment. Abnormalities in neuronal metabolism were associated with cognitive decline, highlighting the importance of neurological monitoring in COVID-19 patients.

BRAIN (2021)

Review Clinical Neurology

Neurovascular-modulation: A review of primary vascular responses to transcranial electrical stimulation as a mechanism of action

Mersedeh Bahr-Hosseini et al.

Summary: The vascular response to transcranial electrical stimulation (tES) involves both primary and secondary phenomena mediated by four cellular elements, with the nature of the response depending on vessel anatomy and physiology. Further research is needed to explore the mechanisms underlying the vascular response and its impact on neural activity in healthy and pathological conditions.

BRAIN STIMULATION (2021)

Article Clinical Neurology

Objective electrophysiological fatigability markers and their modulation through tDCS

Stefanie Linnhoff et al.

Summary: Cognitive fatigability is a common symptom after sustained performance, and it can be objectively assessed by electrophysiological measures. Anodal transcranial direct current stimulation (tDCS) shows potential as a therapeutic intervention for fatigability in neuropsychiatric diseases.

CLINICAL NEUROPHYSIOLOGY (2021)

Article Medicine, Research & Experimental

Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations

Yuanyuan Qin et al.

Summary: The study found that COVID-19 patients showed severe changes in gray matter, white matter, and cerebral blood flow, especially in patients with severe disease. These changes were significantly correlated with inflammatory markers, suggesting that the inflammatory storm may cause indirect brain damage.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients

Ganna Blazhenets et al.

Summary: Cognitive impairment in COVID-19 patients can be related to cortical hypometabolism, which shows reversibility after 6 months. Despite significant recovery, residual impairments remain in some patients.

JOURNAL OF NUCLEAR MEDICINE (2021)

Review Clinical Neurology

Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis

Anthony M. Harrison et al.

Summary: This systematic review and network meta-analysis aimed to estimate the effectiveness of fatigue-targeted and non-fatigue-targeted exercise, behavioural, and combined interventions for multiple sclerosis patients. The results showed that exercise interventions, particularly balance exercises, had significant effects on fatigue symptoms. Recommendations for balance and combined exercise treatments are tentative, with moderate certainty of evidence.

MULTIPLE SCLEROSIS JOURNAL (2021)

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Review Environmental Sciences

Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management

Antoni Siso-Almirall et al.

Summary: Long COVID-19 refers to patients who continue to have signs and symptoms four weeks after the diagnosis of SARS-CoV-2 infection, with an estimated frequency of around 10%. The long-term manifestations are similar to other coronaviruses like SARS and MERS, mainly affecting the respiratory, musculoskeletal, and neuropsychiatric systems. Managing long COVID-19 requires a structured primary care approach, multidisciplinary rehabilitation services, and empowerment of affected patient groups based on limited evidence.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Review Neurosciences

Frontal Transcranial Direct Current Stimulation as a Potential Treatment of Parkinson's Disease-Related Fatigue

Tino Zaehle

Summary: Fatigue is a common non-motor symptom in Parkinson's disease (PD) that significantly impacts quality of life, yet progress in understanding its causes and developing effective treatments is slow. Transcranial direct current stimulation (tDCS) is considered a potential therapeutic option for treating fatigue in patients with neuropsychiatric disorders.

BRAIN SCIENCES (2021)

Article Neurosciences

Intensity-Dependent Changes in Quantified Resting Cerebral Perfusion With Multiple Sessions of Transcranial DC Stimulation

Matthew S. Sherwood et al.

Summary: tDCS of 2-mA stimulation resulted in prominent increased cerebral blood flow (CBF) in various brain regions, including the locus coeruleus (LC) involved in norepinephrine production, while the 1-mA group showed only slight effects, indicating a potential cumulative effect of repeated stimulation on CBF.

FRONTIERS IN HUMAN NEUROSCIENCE (2021)

Review Immunology

Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19

Rakhee K. Ramakrishnan et al.

Summary: COVID-19 has been present for over a year with limited treatment options available. Some recovered patients experience lingering symptoms, known as long COVID-19, possibly due to a persistent immune response causing ongoing inflammation processes.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Review Medicine, General & Internal

Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology

Timothy L. Wong et al.

Summary: Early studies on long COVID symptoms show significant overlaps with ME/CFS, highlighting the need for monitoring and treatment. Further research into the similarities and differences between long COVID and ME/CFS is warranted.

MEDICINA-LITHUANIA (2021)

Article Medicine, General & Internal

European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe

Luis Nacul et al.

Summary: EUROMENE, funded by COST from 2016 to 2020, aims to assess healthcare delivery for individuals with ME/CFS in European countries. The network consists of clinicians, researchers, and health professionals from 22 countries working to improve care for people with ME/CFS.

MEDICINA-LITHUANIA (2021)

Article Respiratory System

Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity

Liam Townsend et al.

Summary: This study reveals that some patients still experience respiratory diseases and subjective symptoms after COVID-19 infection, with ongoing health issues and fatigue often accompanied by a higher perception of exertion. Initial disease severity does not have a strong correlation with persistent respiratory diseases.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Review Immunology

Immune dysregulation and system pathology in COVID-19

Muhammad Jamal et al.

Summary: COVID-19, caused by the novel coronavirus, has led to a global public health crisis with significant confirmed cases and mortalities. Patients exhibit a dysregulated immune response characterized by cytokine storm, increasing the mortality rate. Treatment strategies should focus on antiviral drugs, immunomodulators, and addressing underlying comorbidities.

VIRULENCE (2021)

Review Clinical Neurology

Brain anatomical correlates of fatigue in multiple sclerosis

Miklos Palotai et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Fatigue in multiple sclerosis is associated with multimodal interoceptive abnormalities

Cecilia Gonzalez Campo et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Gastroenterology & Hepatology

A 12-month pilot study outcomes of vagus nerve stimulation in Crohn's disease

Valerie Sinniger et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2020)

Review Clinical Neurology

Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19

Abrahao Fontes Baptista et al.

FRONTIERS IN NEUROLOGY (2020)

Review Neurosciences

Update on the Use of Transcranial Electrical Brain Stimulation to Manage Acute and Chronic COVID-19 Symptoms

Giuseppina Pilloni et al.

FRONTIERS IN HUMAN NEUROSCIENCE (2020)

Article Clinical Neurology

Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis

Andrea Cancelli et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Article Clinical Neurology

Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis

Andrea Cancelli et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Review Endocrinology & Metabolism

Transcranial electrical stimulation (tES) mechanisms and its effects on cortical excitability and connectivity

Thomas Reed et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2018)

Article Behavioral Sciences

Basic and functional effects of transcranial Electrical Stimulation (tES)-An introduction

Fatemeh Yavari et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)

Article Engineering, Biomedical

Counteracting the Slowdown of Reaction Times in a Vigilance Experiment With 40-Hz Transcranial Alternating Current Stimulation

Birte S. Loeffler et al.

IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING (2018)

Review Clinical Neurology

Fatigue in Parkinson's disease: A systematic review and meta-analysis

Mattia Siciliano et al.

MOVEMENT DISORDERS (2018)

Article Engineering, Biomedical

Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinson's disease

Bryan Dobbs et al.

JOURNAL OF NEUROENGINEERING AND REHABILITATION (2018)

Review Immunology

Is there a link between inflammation and fatigue in multiple sclerosis?

Moussa A. Chalah et al.

JOURNAL OF INFLAMMATION RESEARCH (2018)

Article Medicine, Research & Experimental

Task related cerebral blood flow changes of patients with chronic fatigue syndrome: an arterial spin labeling study

Roland Staud et al.

FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR (2018)

Article Clinical Neurology

Transcranial Electrical Stimulation: What We Know and Do Not Know About Mechanisms

Anna Fertonani et al.

NEUROSCIENTIST (2017)

Review Clinical Neurology

The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis

Philippa Miller et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Article Clinical Neurology

Effects of left DLPFC versus right PPC tDCS on multiple sclerosis fatigue

Moussa A. Chalah et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Review Clinical Neurology

Fatigue in multiple sclerosis - Insights into evaluation and management

Samar S. Ayache et al.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY (2017)

Review Neurosciences

Transcranial Alternating Current Stimulation (tACS) Mechanisms and Protocols

Amir V. Tavakoli et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

Article Clinical Neurology

Subjective Cognitive Fatigue and Autonomic Abnormalities in Multiple Sclerosis Patients

Carina Sander et al.

FRONTIERS IN NEUROLOGY (2017)

Letter Clinical Neurology

Long-term effects of tDCS on fatigue, mood and cognition in multiple sclerosis

Moussa A. Chalah et al.

CLINICAL NEUROPHYSIOLOGY (2017)

Article Clinical Neurology

Transcranial direct current stimulation versus caffeine as a fatigue countermeasure

Lindsey K. McIntire et al.

BRAIN STIMULATION (2017)

Letter Clinical Neurology

Long term effects of prefrontal tDCS on multiple sclerosis fatigue: A case study

Samar S. Ayache et al.

BRAIN STIMULATION (2017)

Review Clinical Neurology

Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II

Hsiangkuo Yuan et al.

HEADACHE (2016)

Article Clinical Neurology

Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue

Anna Pokryszko-Dragan et al.

NEUROLOGICAL SCIENCES (2016)

Article Multidisciplinary Sciences

Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis

Frieda A. Koopman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Neurosciences

Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis

Samar S. Ayache et al.

FRONTIERS IN NEUROSCIENCE (2016)

Review Endocrinology & Metabolism

Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?

Miguel D'haeseleer et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)

Review Behavioral Sciences

The roles of cortical oscillations in sustained attention

Michael S. Clayton et al.

TRENDS IN COGNITIVE SCIENCES (2015)

Article Clinical Neurology

Brain plasticity effects of neuromodulation against multiple sclerosis fatigue

Franca Tecchio et al.

FRONTIERS IN NEUROLOGY (2015)

Article Psychology, Biological

Frontal theta activity reflects distinct aspects of mental fatigue

Edmund Wascher et al.

BIOLOGICAL PSYCHOLOGY (2014)

Article Clinical Neurology

Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation

Franca Tecchio et al.

JOURNAL OF NEUROLOGY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis

Maria A. Rocca et al.

RADIOLOGY (2014)

Article Neurosciences

Impact of transcranial direct current stimulation on fatigue in multiple sclerosis

Catarina Saiote et al.

RESTORATIVE NEUROLOGY AND NEUROSCIENCE (2014)

Article Clinical Neurology

Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis

Roberta Ferrucci et al.

NEUROREHABILITATION (2014)

Article Behavioral Sciences

Two types of mental fatigue affect spontaneous oscillatory brain activities in different ways

Yoshihito Shigihara et al.

BEHAVIORAL AND BRAIN FUNCTIONS (2013)

Article Clinical Neurology

Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis

B. Yamout et al.

EUROPEAN JOURNAL OF NEUROLOGY (2013)

Review Clinical Neurology

Fatigue and fatigability in neurologic illnesses Proposal for a unified taxonomy

Benzi M. Kluger et al.

NEUROLOGY (2013)

Editorial Material Biochemistry & Molecular Biology

The neuroethics of non-invasive brain stimulation

Roi Cohen Kadosh et al.

CURRENT BIOLOGY (2012)

Article Psychology, Biological

Regional brain wave activity changes associated with fatigue

Ashley Craig et al.

PSYCHOPHYSIOLOGY (2012)

Review Clinical Neurology

Poststroke fatigue: an emerging, critical issue in stroke medicine

Smi Choi-Kwon et al.

INTERNATIONAL JOURNAL OF STROKE (2011)

Article Clinical Neurology

Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways

J. Sepulcre et al.

MULTIPLE SCLEROSIS JOURNAL (2009)

Article Psychology, Biological

Disrupted sensorimotor gating due to mental fatigue: Preliminary evidence

Dimitri van der Linden et al.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2006)

Article Clinical Neurology

Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone

Nieves Tellez et al.

MULTIPLE SCLEROSIS JOURNAL (2006)

Article Clinical Neurology

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

C Heesen et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)

Article Computer Science, Artificial Intelligence

Effects of mental fatigue on attention: An ERP study

MAS Boksem et al.

COGNITIVE BRAIN RESEARCH (2005)

Article Clinical Neurology

Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis

M Gottschalk et al.

ARCHIVES OF NEUROLOGY (2005)

Article Neurosciences

Consolidation of human motor cortical neuroplasticity by D-cycloserine

MA Nitsche et al.

NEUROPSYCHOPHARMACOLOGY (2004)

Article Multidisciplinary Sciences

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

LV Borovikova et al.

NATURE (2000)

Review Medicine, Research & Experimental

Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome

ML Pall

MEDICAL HYPOTHESES (2000)